[1] KOHLER BA,SHERMAN RL,HOWLADER N,et al.Annual report to the nation on the status of cancer,1975-2011,featuring incidence of breast cancer subtypes by race/ethnicity,poverty,and state[J].J Natl Cancer Inst,2015,107(6):djv048.
[2] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[3] BAUER KR,BROWN M,CRESS RD,et al.Descriptive analysis of estrogen receptor (ER)-negative,progesterone receptor (PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J].Cancer,2007,109(9):1721-1728.
[4] DE FT,ROUSSEL H,HIVELIN M,et al.Atypical distant metastasis of breast malignant phyllodes tumors:A case report and literature review[J].Case Rep Obstet Gynecol,2017,2017(4):1-6.
[5] SUTTER SA,SLINKER A,BALUMUKA DD,et al.Surgical management of breast cancer in Africa:A continent-wide review of intervention practices,barriers to care,and adjuvant therapy[J].J Glob Oncol,2017,3(2):162-168.
[6] RAEMAEKERS T,RIBBECK K,BEAUDOUIN J,et al.NuSAP,a novel microtubule-associated protein involved in mitotic spindle organization[J].J Cell Biol,2003,162(6):1017-1029.
[7] VANDEN BOSCH A,RAEMAEKERS T,DENAYER S,et al.NuSAP is essential for chromatin-induced spindle formation during early embryogenesis[J].J Cell Sci,2010,123(Pt 19):3244-3255.
[8] IYER J,MOGHE S,FURUKAWA M,et al.What's Nu(SAP) in mitosis and cancer[J].Cell Signal,2011,23(6):991-998.
[9] ZHU T,XIE P,GAO YF,et al.Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients[J].CNS Neurosci Ther,2018,24(3):178-186.
[10] CHEN L,YANG L,QIAO F,et al.High levels of nucleolar spindle-associated protein and reduced levels of BRCA1 expression predict poor prognosis in triple-negative breast cancer[J].PLoS One,2015,10(10):e0140572.
[11] ZHANG X,PAN Y,FU H,et al.Nucleolar and spindle associated protein 1 (NuSAP1) inhibits cell proliferation and enhances susceptibility to epirubicin in invasive breast cancer cells by regulating Cyclin D kinase (CDK1) and DLGAP5 expression[J].Med Sci Monit,2018,24(9):8553-8564.
[12] GUAN C,LIU Z,LU C,et al.Nucleolar spindle-associated protein 1 promotes tumorigenesis and predicts poor prognosis in human esophageal squamous cell carcinoma[J].J Cell Biochem,2019,2(120):11726-11737.
[13] GARRIDO-RODRIGUEZ M,ORTEA I,CALZADO MA,et al.SWATH proteomic profiling of prostate cancer cells identifies NuSAP1 as a potential molecular target for Galiellalactone[J].J Proteomics,2019,193(9):217-229.
[14] LIU Z,GUAN C,LU C,et al.High NuSAP1 expression predicts poor prognosis in colon cancer[J].Pathol Res Pract,2018,214(7):968-973.
[15] FANG L,ZHANG M,CHEN L,et al.Downregulation of nucleolar and spindle associated protein 1 expression suppresses cell migration,proliferation,and invasion in renal cell carcinoma[J].Oncol Rep,2016,36(3):1506-1516.
[16] FAN D,REN B,YANG X,et al.Upregulation of miR-501-5p activates the wnt/beta-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer[J].J Exp Clin Cancer Res,2016,35(1):177.
[17] CHIACCHIERA F,ROSSI A,JAMMULA S,et al.Polycomb complex PRC1 preserves intestinal stem cell identity by sustaining Wnt/beta-Catenin transcriptional activity[J].Cell Stem Cell,2016,18(1):91-103.
[18] HSEU YC,LIN YC,RAJENDRAN P,et al.Antrodia salmonella suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-kappaB and Wnt/beta-catenin signaling pathway[J].Food Chem Toxicol,2019,124(2):219-230.
[19] GE Z,LI LF,WANG CY,et al.CircMTO1 inhibits cell proliferation and invasion by regulating Wnt/beta-catenin signaling pathway in colorectal cancer[J].Eur Rev Med Pharmacol Sci,2018,22(23):8203-8209.
[20] NIETO MA,HUANG RY,JACKSON RA,et al.EMT:2016[J].Cell,2016,166(1):21-45.
[21] JOLLY MK,CELIA-TERRASSA T.Dynamics of phenotypic heterogeneity associated with EMT and stemness during cancer progression[J].J Clin Med,2019,8(10):1542-1562.
[22] HUBER MA,KRAUT N,BEUG H.Molecular requirements for epithelial-mesenchymal transition during tumor progression[J].Curr Opin Cell Biol,2005,17(5):548-558.
[23] MOUSTAKAS A,HELDIN CH.Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression[J].Cancer Sci,2007,98(10):1512-1520.
[24] THIERY JP,ACLOQUE H,HUANG RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890.
[25] TAJBAKHSH A,RANDI M,ABEDINI S,et al.Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC):A review[J].Crit Rev Oncol Hematol,2019,140(9):17-27.
[26] ZHANG FL,CAO JL,XIE HY,et al.Cancer-associated MORC2-mutant M276I regulates an hnRNPM-mediated CD44 splicing switch to promote invasion and metastasis in triple-negative breast cancer[J].Cancer Res,2018,78(20):5780-5792.
[27] DEN BROK WD,SPEERS CH,GONDARA L,et al.Survival with metastatic breast cancer based on initial presentation,de novo versus relapsed[J].Breast Cancer Res Treat,2017,161(3):549-556.
[28] KHOSRAVI-SHAHI P,CABEZON-GUTIERREZ L,APARICIO SALCEDO MI.State of the art of advanced triple-negative breast cancer[J].Breast J,2019,25(5):967-970
[29] FULTANG N,ILLENDULA A,CHEN B,et al.Strictinin,a novel ROR1-inhibitor,represses triple-negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ss activity[J]. PLoS One,2019,14(5):e0217789.
[30] AHMED K,KOVAL A,XU J,et al.Towards the first targeted therapy for triple-negative breast cancer:Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor[J].Cancer Lett,2019,449(5):45-55.
[31] XU Z,WANG Y,XIONG J,et al.NuSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling[J].J Cell Physiol,2019,2(12):1-8.
[32] CHEN Z,WU W,HUANG Y,et al.RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT[J].J Cancer,2019,10(27):6837-6847.
[33] WEI Y,ZHANG F,ZHANG T,et al.LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/beta-catenin/EMT signaling cascade in gastric cancer[J].Aging (Albany NY),2019,11(20):8951-8968.
[34] 孙莉.NuSAP1通过Wnt/β-catenin及EMT通路促进乳腺癌细胞增殖和侵袭及预测预后价值的研究[D].沈阳:中国医科大学,2020.
SUN L.Overexpression of NuSAP1 is predictive of unfavorable prognosis and promotes triple-negative breast cancer tumorigenicity via the Wnt/β-catenin/EMT signaling axis[D].Shenyang:China Medical University,2020.